Back to
Vanguard Group Inc.
VKTX
6 quarters
Position history for
Vanguard Group Inc.'s holdings in Viking Therapeutics, Inc.
As of its last 13F, for Q4 2025, Vanguard Group held 9,984,487 shares of VKTX (Viking Therapeutics), worth $351.3M. It reduced the position by 14,620 shares (-0.2%) from Q3 2025. Vanguard Group held VKTX from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.
Current Value
$351.3M
Current Shares
10M
Total Value Change
-$292.5M
Total Shares Change
-183,127
Quarter-by-Quarter History
Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.